Back to Search Start Over

Atezolizumab: Cerebellar ataxia: case report.

Source :
Reactions Weekly. 11/23/2019, Vol. 1780 Issue 1, p52-52. 1p.
Publication Year :
2019

Abstract

A 66-year-old man developed cerebellar ataxia following treatment with atezolizumab for non-small-cell lung cancer. Differential diagnoses included treatment-related toxicities or a paraneoplastic syndrome. Case report: immune-mediated cerebellar ataxia secondary to anti-PD-L1 treatment for lung cancer. [Extracted from the article]

Subjects

Subjects :
*CEREBELLAR ataxia
*CEREBELLAR cortex
*CARBOPLATIN
*NON-small-cell lung carcinoma
*PARANEOPLASTIC syndromes

Details

Language :
English
ISSN :
01149954
Volume :
1780
Issue :
1
Database :
Academic Search Index
Journal :
Reactions Weekly
Publication Type :
Periodical
Accession number :
139811889
Full Text :
https://doi.org/10.1007/s40278-019-71544-8
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details